MAb

Related by string. MAB * * WAM MAB . Butlers Plc MAB LN . monoclonal antibodies MAbs . monoclonal antibodies mAbs . monoclonal antibody mAb . monoclonal antibody IgG1 Mab . monoclonal antibody MAb . CCR5 mAb . Mab Ta Phut . Queen Mab . OvaRex ® MAb . flu mAb . Service MABS . OvaRex MAb . MAbs targeting . MAb therapy . D mab . ee LIM uh mab . Biosphere MAB . therapeutic mAbs . antibody MAb *

Related by context. All words. (Click for frequent words.) 71 humanized antibody 70 Gleevec resistant 70 anti CD3 70 pan HDAC inhibitor 68 monoclonal 68 mAb 68 polyclonal antibody 68 BiTE 68 EpCAM 67 chimeric monoclonal antibody 67 HDACi 67 targeting CD# 67 OvaRex R 67 vidofludimus 67 RAV# 67 Vidofludimus 67 CD# antibody [001] 67 IMA# 67 Factor VIIa 67 vascular disrupting agents 67 Azedra 67 MAbs 67 GRNVAC1 66 adenoviral 66 IMC A# 66 ESBA# 66 KSP inhibitor 66 TNF α 66 liposomal formulation 66 XmAb# 66 targeted antifolate 66 Traficet EN 66 TG# [003] 66 effector function 66 Onconase 66 Aurora kinase 66 depsipeptide 66 CDK inhibitor 66 selective kinase inhibitor 66 CCX# 66 humanized monoclonal antibodies 66 VEGF receptor 66 Xanafide 66 T#I [002] 66 Symadex 66 humanized monoclonal antibody 66 ENMD # 66 Kahalalide F 66 IgG1 antibody 66 JAK3 66 Sym# 66 oral prodrug 66 PEGylated 66 bispecific antibody 65 siRNA therapeutic 65 selective modulator 65 proteasome inhibitor 65 novel peptide 65 HER2 antibody 65 YONDELIS 65 receptor tyrosine kinase inhibitor 65 rituximab Rituxan 65 humanized monoclonal 65 mAbs 65 volociximab 65 protein kinase inhibitor 65 IL 1ß 65 HuMax CD4 65 mertansine 65 monoclonal antibody mAb 65 Dalbavancin 65 Liposomal 65 molecularly targeted 65 PI3K inhibitor 65 EGF receptor 65 HQK 65 targeted radiotherapeutic 65 tyrosine kinase inhibitor 65 decitabine 65 FVIIa 65 histone deacetylase inhibitor 65 therapeutic monoclonal antibody 65 Aplidin 65 PEG SN# 65 solithromycin 65 immunostimulatory 64 humanized anti 64 Pemetrexed 64 tumor antigen 64 Interferon alfa 64 LEX System 64 polyclonal 64 cancer immunotherapies 64 hA# 64 EZN 64 CD# antibodies 64 angiogenesis inhibitor 64 micafungin 64 tubulin inhibitor 64 Monoclonal Antibody 64 CD# monoclonal antibody 64 Bortezomib 64 orally administered inhibitor 64 CYC# 64 Tesetaxel 64 MEK inhibitors 64 antibody 64 antibody MAb 64 SIRT2 64 Panzem 64 Pertuzumab 64 SERMs 64 antitumor 64 delafloxacin 64 IMC #B 64 estrogen receptor beta 64 PSN# [002] 64 Micromet BiTE 64 favorable pharmacokinetic profile 64 Zolinza 64 indibulin 64 GRN#L 64 Trastuzumab 64 DAVANAT 64 HDAC Inhibitor 64 FLT3 64 Nanobody 64 interferon IFN 64 Fc fusion protein 64 monoclonal antibody MAb 64 Thrombin 64 alefacept 64 anti CD# antibodies 64 Anticalin ® 64 intratumoral injection 64 JAK inhibitor 64 investigational humanized monoclonal antibody 64 EGFr 64 BCR ABL inhibitors 64 Archexin 64 MUC1 64 ErbB3 64 pro angiogenic 64 AEG# 64 flavopiridol 64 Anticalins ® 64 selective agonist 64 receptor monoclonal antibody 64 small molecule tyrosine 64 FK# 64 cytotoxicity assays 64 Olaparib 64 HuMax CD# 64 pertussis toxin 64 PKC# 64 multitargeted 63 histone deacetylase HDAC inhibitor 63 TLR9 agonist 63 interleukin IL -# 63 TNFa 63 MGd 63 IFN α 63 Neuvenge 63 Interferon beta 63 Granulocyte Colony Stimulating Factor 63 Anticalins R 63 preclinically 63 Anavex #-# 63 HSP# inhibitor 63 PI3K inhibitors 63 inhibit EGFR 63 potent antiproliferative 63 #HT#A 63 cytostatic 63 tafamidis 63 Carfilzomib 63 immunoregulatory 63 annexin 63 ALK inhibitor 63 Monoclonal antibody 63 antibody fragment 63 Annexin V 63 immunomodulator 63 anticancer agent 63 murine monoclonal antibody 63 IL #E 63 splice variant 63 vWF 63 Fenretinide 63 5alpha reductase 63 Onalta ™ 63 transfected cells 63 radiolabeled 63 Aplidin R 63 cilengitide 63 Virulizin ® 63 Quinamed 63 T#I mutant 63 gefitinib Iressa 63 monoclonal antibody 63 nucleoside analog 63 PrevOnco 63 investigational monoclonal antibody 63 PC# cells 63 tumor xenograft models 63 L asparaginase 63 JAK1 63 EndoTAG TM -1 63 delta isoform 63 anti angiogenic agent 63 CBLC# 63 HER2/neu 63 Erlotinib 63 CD3 monoclonal antibody 63 kinase inhibition 63 Bezielle 63 immune modulating 63 IFN alpha 63 xenograft models 63 caspofungin 63 DermaVir Patch 63 Janus kinase 63 IL #p# 63 PDE4 inhibitor 63 qRT PCR 63 Preclinical studies suggest 63 Vandetanib 63 rhIL 7 63 miR #a [001] 63 Anticalin R 63 multikinase inhibitor 63 PEGylated interferon 63 TNFα 63 Dasatinib 63 huC# DM4 63 humanized antibodies 63 antiangiogenic 63 IMP# 63 interleukin IL 63 mTOR inhibitors 63 Pazopanib 63 MEK inhibitor 63 selective inhibition 63 OMP #M# 63 uricase 63 TTR gene 63 Milatuzumab 63 proteolytic cleavage 63 Talotrexin 62 Alferon N 62 monomeric 62 Degarelix 62 TNFalpha 62 EndoTAG 62 ERK1 2 62 Gefitinib 62 Maribavir 62 lymphoid cells 62 therapeutic monoclonal antibodies 62 Doxorubicin 62 leukemia AML 62 peptide antigens 62 FluCide 62 cancer vaccine Norelin 62 highly immunogenic 62 Vorinostat 62 cyclin E 62 orally dosed 62 RhuDex ® 62 HuLuc# 62 SGLT 62 Pralatrexate 62 PSMA ADC 62 anti amnesic 62 Epratuzumab 62 preclinical efficacy 62 rhFVIIa 62 Nanobodies 62 survivin 62 intranasal formulation 62 hypoxia inducible factor 62 pomalidomide 62 CA4P 62 histone deacetylase HDAC 62 epigenetic therapies 62 Aptivus ® 62 CCL# 62 transgene expression 62 colon carcinoma 62 Epidermal Growth Factor Receptor 62 c MET 62 Calcitonin 62 cytokine IL 62 subcutaneously administered 62 protein tyrosine phosphatase 1B 62 NS#/#A protease 62 AVI NEUGENE 62 muscarinic 62 hTERT 62 NY ESO 62 Taxol ® 62 glycosylated 62 selective antagonist 62 HCV replicon 62 GV# [001] 62 recombinant antibodies 62 fosbretabulin 62 LB# [003] 62 TGF beta1 62 IGF IR 62 vivo validation 62 Amrubicin 62 orally bioavailable 62 DOS# 62 Panzem R NCD 62 Decitabine 62 PEG IFN 62 Mucosal 62 nanomolar range 62 HIF 1a 62 hepatoma 62 CYT# potent vascular disrupting 62 ONCONASE R 62 radiation sensitizer 62 Octreotide 62 XmAb 62 chemokine receptor 62 antiangiogenesis 62 inhibiting tumor 62 biologic therapeutics 62 CIMZIA TM 62 Cethromycin 62 synthetic peptide 62 pDCs 62 torezolid 62 JAK inhibitors 62 cynomolgus monkeys 62 intravesical instillation 62 p# inhibitor 62 ceftazidime 62 Elotuzumab 62 epothilone 62 antisense inhibition 62 Pradefovir 62 peptidomimetic 62 cetuximab Erbitux R 62 HepG2 cells 62 antisense oligonucleotide 62 activin 62 TBC# 62 Tarvacin 62 Eg5 62 AKT inhibitor 62 selective adenosine 62 novel histone deacetylase 62 A3 adenosine receptor 62 Daclizumab 62 PORxin TM 62 BAY #-# 62 MAGE A3 62 somatostatin 62 GHRH 62 OHR/AVR# 62 nucleoside 62 antiproliferative effects 62 PARP inhibitor 62 somatostatin analogue 62 CCR9 62 NFkB 62 immunomodulation 62 Dapagliflozin 62 synthetic siRNA 62 IgG antibodies 62 microtubule inhibitor 62 CIMZIA ™ 62 XL# XL# 62 lumiliximab 62 IGF 1R 62 JAK#/JAK# 62 androgen receptor AR 62 pegylated liposomal doxorubicin 62 nanomolar 62 Blinatumomab 62 CYT# 62 mapatumumab 62 DXL# 62 malignant ascites 62 CHO cells 62 SIR Spheres 62 anti EGFR antibody 62 Thiarabine 62 Romidepsin 62 drug conjugate 62 PI3K Akt 62 tumorigenicity 62 vitro assay 62 alpha#beta# integrin 62 PRTX 62 non nucleoside 62 tumorigenic 62 Aflibercept 62 adipogenic 62 compound AEZS 62 cytotoxin 62 HGS ETR2 62 ATL/TV# 62 ALN TTR# 62 Aptamer 62 poly ADP ribose polymerase 62 Omacetaxine 62 PBMCs 62 BZL# 62 erlotinib Tarceva ® 61 HER3 61 fluoropyrimidine 61 DNA intercalator 61 K ras mutations 61 trastuzumab Herceptin 61 HGS# 61 FasL 61 Tarvacin TM 61 IgG1 61 colony stimulating factor 61 PXD# 61 CG# [003] 61 miR #a [002] 61 telomerase therapeutic 61 isotype 61 Telatinib 61 Bevirimat 61 osteogenic 61 antisense drug 61 corticosteroid dexamethasone 61 ERK phosphorylation 61 HuMax 61 imatinib Gleevec 61 CCR9 antagonist 61 5 HT2C receptor 61 EGFR antibodies 61 GRASPA ® 61 mediated inhibition 61 Myocet 61 TGR5 61 tiuxetan 61 XL# inhibits 61 NOX E# 61 Irinotecan 61 Anticalin 61 Onalta 61 rFIXFc 61 parthenolide 61 CCR5 antagonist 61 thymalfasin 61 galiximab 61 cytokine signaling 61 sodium glucose cotransporter 61 HEK# cells 61 IFN beta 61 Multimeric 61 anti CD3 antibody 61 ADAMTS# 61 IAP inhibitor 61 cytotoxic T lymphocyte 61 tumor necrosis 61 JAK2 inhibitors 61 Alocrest 61 recombinant protein 61 Luteinizing Hormone Releasing Hormone 61 HCV protease 61 potent inhibitor 61 Rebif ® 61 heterologous 61 HDAC inhibitor 61 VSV G 61 phosphoprotein 61 Lenalidomide 61 S/GSK# 61 Leukine ® 61 TLR agonists 61 erlotinib Tarceva 61 neurotrophic factor 61 LHRH agonists 61 Nilotinib 61 pegylated 61 HspE7 61 PTHrP 61 OXi# 61 myeloma cells 61 Natalizumab 61 biliary tract cancer 61 PEGPH# 61 IL# PE#QQR 61 XmAb ™ 61 AEGR 61 nanoviricides 61 HCD# [002] 61 ISF# 61 chemotherapeutic drug 61 NXL# 61 bispecific 61 Bruton tyrosine kinase Btk 61 anticancer compound 61 myelofibrosis polycythemia vera 61 imatinib Gleevec ® 61 Proxinium TM 61 antitumoral 61 TELCYTA 61 dexpramipexole 61 INCB# [001] 61 Azacitidine 61 GAP #B# 61 milatuzumab 61 OncoVEX 61 antiangiogenic therapy 61 picomolar 61 pancreatic carcinoma 61 HIF PHI 61 Locked Nucleic Acid LNA 61 mutated KRAS 61 epithelial tumors 61 EGFR HER2 61 proteasome inhibitors 61 HCV protease inhibitor 61 Interferon Beta 61 humanised monoclonal antibody 61 Survivin 61 luteinizing hormone releasing 61 PDGF receptor 61 LY# [002] 61 thrombin receptor 61 P#X# 61 polymerase inhibitor 61 cleavable linker 61 concurrent chemoradiation 61 TRAIL R2 61 BRAF inhibitor 61 S#P# 61 metastatic RCC 61 Fleximer 61 immunotherapeutic 61 CTGF 61 ganetespib 61 MAGE A3 ASCI 61 nanoviricide drug 61 Squalamine 61 elacytarabine 61 cannabinor 61 immune modulator 61 RECOTHROM R 61 CLORETAZINE TM VNP#M 61 polyclonal antibodies 61 Antigenics QS 61 vivo potency 61 interleukins 61 ON #.Na 61 cyclin dependent kinase inhibitor 61 selectively inhibited 61 plasmid DNA vaccine 61 peripherally acting 61 LY# [003] 61 Nexavar sorafenib 61 Cloretazine 61 LHRH agonist 61 YONDELIS R 61 Amplimexon 61 inhibit viral replication 61 lipopeptide 61 Curaxin 61 Epirubicin 61 recombinant factor VIIa 61 antisense oligonucleotides 61 Monoclonal 61 trans retinoic acid 61 mda 7 61 bleomycin 61 factor Xa 61 prodrug 61 mimetics 61 IFN γ 61 Temsirolimus 61 HyperAcute 61 siRNA mediated 61 Trp p8 61 Chemokine Receptor 61 irreversible inhibitor 61 prodrugs 61 NS4A 61 OncoVEX GM CSF 61 immune modulatory 61 receptor blocker 61 Anticalins 61 Golimumab 61 selective immunoproteasome inhibitor 61 vinorelbine tartrate 61 TGF β 61 radiotherapeutic 61 monoclonal antibodies 61 midkine 61 Akt activation 61 ANG# 61 LEUKINE 61 HyACT 61 vinca alkaloid 61 PARP inhibition 61 immunomodulatory therapy 61 NTDDS 61 metastatic neuroendocrine tumors 61 liposomal doxorubicin 61 potent inhibition 61 plasmid encoding 61 receptor antagonists 61 LHRH 61 HepaGam B 61 BrachySil TM 61 PEP# [003] 61 Janus Kinase 61 TLR8 61 Laquinimod 61 neurotrophic 61 Ganciclovir 61 bortezomib Velcade 61 carbohydrate polymer 61 Polymer Microspheres 61 camptothecin 61 personalized immunotherapy 61 CCR1 61 mesothelin 61 sd rxRNA 61 MyVax R 61 BMS# 61 BCR ABL 61 huN# DM1 61 pegfilgrastim 61 Th2 cytokines 61 EOquin 61 immunoconjugate 61 thrombopoietin 61 TKM ApoB 61 Civacir 61 EGFR receptor 61 pharmacokinetic interactions 61 demonstrated antitumor activity 61 Tyrima 61 Cloretazine VNP#M 61 immune stimulatory 61 MORAb 61 WT1 60 Omacetaxine mepesuccinate 60 anti leukemic 60 thalidomide Thalomid 60 HGF 60 epothilones 60 HER1 60 Vaprisol 60 VitiGam 60 recombinant FVIII 60 immunofluorescence staining 60 Litx 60 keratinocyte 60 endostatin 60 BAL# [002] 60 Assay Kits 60 Lixivaptan 60 #ME# 60 TGF ß 60 mediated apoptosis 60 sorafenib Nexavar 60 bexarotene 60 miRs 60 Enzastaurin 60 Rituximab 60 JVRS 60 HDAC 60 LEP ETU 60 FGFR 60 5 HT6 receptor 60 Interferon alpha 60 busulfan 60 cytoprotective 60 cMET 60 JAK2 inhibitor 60 MT#/MEDI-# 60 selective orally bioavailable 60 SPRYCEL ® 60 Smac mimetic 60 tumor specific antigen 60 HCV protease inhibitors 60 Bendavia 60 Anidulafungin 60 CTLA 4 60 LT NS# 60 Neulasta ® 60 gastrointestinal stromal tumors GIST 60 protein tyrosine phosphatase 60 therapeutic antibody 60 antiangiogenic agent 60 IFN gamma 60 BiTE antibody 60 Beta catenin pathway 60 cediranib 60 tigecycline 60 HuMax EGFr 60 ERK pathway 60 trabectedin 60 Etoposide 60 human monoclonal antibody 60 TRX1 60 nutlin 60 Interferon Gamma 60 DiLA2 60 SAR# [004] 60 CCR2 60 K#R [002] 60 IRX 2 60 MYDICAR ® 60 oncolytic virus 60 ganciclovir 60 p# biomarker 60 factor HGF 60 Tamibarotene 60 SCH # 60 M1 muscarinic 60 secretory pathway 60 Flt3 60 EndoTAG TM 60 inhibitory effects 60 glatiramer 60 LTB4 60 isoform selective 60 ibritumomab tiuxetan 60 Copegus ribavirin 60 Angiolix 60 MKC# MT 60 idarubicin 60 PAM4 60 replicon 60 Recombinant Human 60 entinostat 60 antibody cytokine 60 sipuleucel T 60 AQ4N 60 microRNA miR 60 synthetic peptides 60 VA# [002] 60 iNOS 60 pDC 60 pharmacodynamic profile 60 biologic therapies 60 novel prodrug 60 Zysolin TM 60 enzastaurin 60 Universal Flu Vaccine 60 aminoglycoside 60 AAG geldanamycin analog 60 EGFR tyrosine kinase inhibitors 60 Cannabinor 60 docetaxel Taxotere ® 60 somatostatin analogues 60 LEAPS TM 60 etanercept Enbrel 60 IFN g 60 HTS assay 60 microglial activation 60 eIF 4E 60 denileukin diftitox 60 immunotoxin 60 chemopreventive agent 60 Pegylated 60 IGF1R 60 osteoblast 60 INT# [002] 60 SNT MC# 60 Insegia 60 kinase inhibitors 60 antitumor effect 60 Elagolix 60 5 HT2C 60 Cyclosporine 60 relapsed leukemia 60 antisense inhibitor 60 mGlu2 3 60 vaccine GRNVAC1 60 ATL# [001] 60 oral JAK1 60 Icatibant 60 PI3K/Akt pathway inhibitor 60 Aliskiren 60 Kinoid 60 therapeutic mAbs 60 Nanobodies ® 60 P selectin 60 rxRNA 60 tyrosine kinase receptor 60 NSCLC tumors 60 BNC# 60 Removab 60 Japanese Encephalitis vaccine 60 sunitinib malate 60 virus AAV 60 TRO# 60 gastrointestinal stromal tumors GISTs 60 Bleomycin 60 subunit vaccines 60 conjugates 60 IFN ß 60 osteoclast 60 trastuzumab DM1 T DM1 60 PKCi 60 Cathepsin S 60 Genentech Rituxan 60 metastatic malignant 60 multi kinase inhibitor 60 anticancer therapeutics 60 metaglidasen 60 peroxidase 60 soluble tumor necrosis 60 ALN TTR 60 Akt inhibitor 60 TLR antagonist 60 C5aR 60 effector functions 60 azacytidine 60 amphotericin B 60 Factor Receptor 60 DACH platinum 60 GnRH antagonist 60 tanespimycin 60 ZK EPO 60 GPNMB 60 AGTR1 60 pitavastatin 60 ovarian carcinoma 60 Fibroblast Growth Factor Receptor 60 humanised antibody 60 Alfacell proprietary ribonuclease 60 chemoresistant 60 costimulation 60 stable nucleic acid 60 immunofluorescence microscopy 60 Immunohistochemical staining 60 rFSH 60 uPA 60 oral antiviral 60 bactericidal activity 60 MGCD# [001] 60 #T# L1 60 cytokeratin 60 glycosylation profile 60 M2 subunit 60 PPARgamma 60 alpha interferon 60 Glufosfamide 60 lysosomal 60 VAPRISOL 60 Prolastin C 60 VEGFR2 60 cytotoxic agents 60 NeoLipid R 60 Bruton tyrosine kinase 60 Aurora Kinase 60 Cintredekin Besudotox 60 adrenoceptor 60 lymphoid malignancies 60 superficial bladder cancer 60 MDR1 60 potent cytotoxic 60 tumor xenografts 60 ORENCIA R 60 Chronic Myeloid Leukemia CML 60 E#F# 60 ZEVALIN ® 60 xenograft tumors 60 BoNT 60 MT# MEDI 60 cell lysis 60 Cyclosporin 60 receptor CD# 60 anti CD# antibody 60 teriflunomide 60 Triapine 60 peritoneal carcinomatosis 60 antitumor efficacy 60 peripheral blood mononuclear 60 Peregrine bavituximab 60 Pimavanserin 60 elotuzumab 60 Mipomersen 60 VEGFR1 60 ENaC 60 NOD SCID mice 60 Soliris eculizumab 60 gastrin 60 CANCIDAS 60 Antiangiogenic 60 Campath ® 60 TRAIL Receptor 60 ONTAK 60 transfection reagents 60 serine protease 60 Camptothecin 60 Sudhir Agrawal D.Phil 60 BCG refractory 60 somatostatin receptor 60 Bavituximab 60 BrachySil 60 dSLIM 60 MKC# MKC# PP 60 xenograft 60 regorafenib 60 Plenaxis TM 60 antidiabetic 60 Ceflatonin 60 carcinoembryonic antigen 60 Leuprolide 60 PRT# 60 HER2 receptor 60 lentiviral vector 60 Paraplatin ® 60 CD4 + CD# 60 vascular disrupting agent 60 pharmacological chaperone 60 mTOR inhibitor 60 Atiprimod 60 human hepatocytes 60 DCVax R 60 CRLX# 60 OMP #R# 60 ZACTIMA 60 SGLT 2 60 PNP inhibitor 60 eNOS 60 panitumumab Vectibix 60 mannose 60 R#/MEM # 60 sclerostin 60 anti angiogenic drugs 60 echinocandin 60 vitro cytotoxicity 60 MTT assay 60 mitomycin 60 RAF kinase 60 Triolex 60 DUROS 60 TroVax ® 60 APOPTONE 60 IMiDs R 60 Oral NKTR 60 Fluconazole 60 Seliciclib 60 cytotoxic 60 phosphate S1P 60 TheraCIM 60 vorinostat 60 LHRH antagonist 60 ELISPOT assay 60 chemotherapy induced neutropenia 60 Belerofon 59 Immunotherapeutic 59 radezolid 59 isoenzyme 59 syngeneic 59 annexin V 59 mecamylamine 59 Inhalation Solution 59 Targretin 59 Hycamtin 59 IAP inhibitors 59 vascular disrupting 59 Safinamide 59 mouse xenograft models 59 CD4 monoclonal antibody 59 transgenic mouse models 59 cytolytic 59 PPAR gamma agonists 59 neuroregenerative 59 Doxil ® 59 proteasome inhibitor bortezomib 59 ZOLINZA 59 tolevamer 59 #D#C# 59 serum antibodies 59 FGFR3 59 pancreatic enzyme replacement 59 MVA BN 59 antithrombotic 59 Kinase Inhibitor 59 antisense inhibitors 59 gastric adenocarcinoma 59 NKG2D 59 meropenem 59 59 mu opioid receptor antagonist 59 Tofacitinib 59 UPLYSO 59 HER2 ErbB2 59 transmembrane protein 59 K ras 59 farletuzumab 59 florbetaben

Back to home page